Intech Investment Management LLC Sells 27,512 Shares of Trupanion, Inc. $TRUP

Intech Investment Management LLC decreased its stake in shares of Trupanion, Inc. (NASDAQ:TRUP) by 60.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 17,726 shares of the financial services provider’s stock after selling 27,512 shares during the period. Intech Investment Management LLC’s holdings in Trupanion were worth $662,000 at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in the stock. Thrivent Financial for Lutherans increased its position in shares of Trupanion by 1.1% during the second quarter. Thrivent Financial for Lutherans now owns 24,853 shares of the financial services provider’s stock worth $1,376,000 after acquiring an additional 282 shares in the last quarter. EP Wealth Advisors LLC increased its position in shares of Trupanion by 2.9% during the second quarter. EP Wealth Advisors LLC now owns 10,310 shares of the financial services provider’s stock worth $571,000 after acquiring an additional 292 shares in the last quarter. PNC Financial Services Group Inc. raised its position in Trupanion by 21.7% in the 3rd quarter. PNC Financial Services Group Inc. now owns 2,678 shares of the financial services provider’s stock valued at $116,000 after buying an additional 478 shares during the last quarter. AlphaQuest LLC lifted its stake in Trupanion by 16.5% in the 3rd quarter. AlphaQuest LLC now owns 3,444 shares of the financial services provider’s stock valued at $149,000 after acquiring an additional 487 shares in the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in Trupanion by 3.8% during the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 20,340 shares of the financial services provider’s stock worth $1,126,000 after acquiring an additional 737 shares during the last quarter.

Insider Transactions at Trupanion

In other news, COO John R. Gallagher sold 3,603 shares of the firm’s stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $21.69, for a total transaction of $78,149.07. Following the completion of the sale, the chief operating officer owned 33,065 shares in the company, valued at approximately $717,179.85. This trade represents a 9.83% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CFO Fawwad Qureshi sold 6,177 shares of the firm’s stock in a transaction dated Wednesday, May 27th. The stock was sold at an average price of $22.18, for a total transaction of $137,005.86. Following the sale, the chief financial officer owned 2,081 shares of the company’s stock, valued at approximately $46,156.58. This represents a 74.80% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last 90 days, insiders have sold 11,132 shares of company stock valued at $248,680. 5.58% of the stock is currently owned by corporate insiders.

Trupanion Stock Performance

Shares of TRUP opened at $22.05 on Tuesday. The firm has a 50-day moving average of $24.45 and a 200-day moving average of $29.60. The company has a debt-to-equity ratio of 0.25, a current ratio of 1.73 and a quick ratio of 1.73. The company has a market cap of $961.82 million, a PE ratio of 37.37 and a beta of 1.45. Trupanion, Inc. has a one year low of $21.16 and a one year high of $57.88.

Trupanion (NASDAQ:TRUP) last posted its earnings results on Thursday, April 30th. The financial services provider reported $0.11 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.07 by $0.04. The company had revenue of $384.05 million during the quarter, compared to analysts’ expectations of $379.77 million. Trupanion had a net margin of 1.74% and a return on equity of 6.87%. Trupanion’s quarterly revenue was up 12.3% compared to the same quarter last year. During the same quarter last year, the company posted ($0.03) EPS. As a group, equities analysts forecast that Trupanion, Inc. will post 0.53 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on TRUP. Stifel Nicolaus reduced their price target on Trupanion from $35.00 to $31.00 and set a “hold” rating for the company in a research report on Tuesday, March 31st. Zacks Research downgraded shares of Trupanion from a “strong-buy” rating to a “hold” rating in a research report on Friday, February 13th. Cantor Fitzgerald decreased their target price on shares of Trupanion from $42.00 to $34.00 and set a “neutral” rating for the company in a research report on Thursday, April 9th. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Trupanion in a research report on Monday, June 1st. Finally, Bank of America decreased their target price on shares of Trupanion from $63.00 to $59.00 and set a “buy” rating for the company in a research report on Tuesday, April 14th. Two research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Trupanion presently has an average rating of “Hold” and a consensus price target of $42.25.

Trupanion Profile

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.